Benzinga | May 6, 2021 07:51AM EDT

Ironwood Pharmaceuticals Q1 EPS $0.24 Beats $0.21 Estimate, Sales $88.84M Miss $95.20M Estimate

Ironwood Pharmaceuticals (NASDAQ:IRWD) reported quarterly earnings of $0.24 per share which beat the analyst consensus estimate of $0.21 by 14.29 percent. This is a 500 percent increase over earnings of $0.04 per share from the same period last year. The company reported quarterly sales of $88.84 million which missed the analyst consensus estimate of $95.20 million by 6.68 percent. This is a 11.14 percent increase over sales of $79.94 million the same period last year.